IL2RG and combined immunodeficiency: To evaluate the effect of XRC treatment on editing in long-term engrafting HSCs, we transplanted edited SC SC HSPCs and SC XRC HSPCs into immunodeficient non-obese diabetic (NOD) severe combined immunodeficiency (SCID) Il2rg−/− (NSG) mice (Figure 6A).